Item 5. Other Information
Item
5. OTHER INFORMATION
(a)
None.
(b)
During
the quarter ended March 31, 2023, there have not been any material changes to the procedures by which security holders may recommend
nominees to the Board of Directors.
Item
6. EXHIBITS
The
following documents are filed as part of this report:
Exhibit
No.
Description
2.1
Share
Exchange Agreement dated April 5, 2018 by and among Newmarkt Corp., the shareholders of Ozop Surgical, Inc., Ozop Surgical, Inc.
and Denis Razvodovskij (Incorporated by reference to Exhibit 2.1 of the Current Report on Form 8-K filed on April 19, 2018).
2.2
Stock
Purchase Agreement dated June 26, 2020, by and among Ozop Surgical Corp., Power Conversion Technologies, Inc. and Catherine Chis
(Incorporated by reference to Exhibit 10.1 of the Current Report on Form 8-K filed on June 29, 2020).
2.3
Merger
Agreement and Plan of Merger between Ozop Surgical Corp. and Ozop Surgical Name Change Subsidiary, Inc. (Incorporated by reference
to Exhibit 2.1 of the Current Report on Form 8-K filed on November 13, 2020).
3.1
Articles
of Incorporation (Incorporated by reference to our General Form for Registration of Securities on Form S-1 filed on August 1, 2016)
3.2
Bylaws
(Incorporated by reference to our General Form for Registration of Securities on Form S-1 filed on August 1, 2016)
3.3
Certificate
of Amendment of Amended and Restated Articles of Incorporation as filed with the Nevada Secretary of State on May 8, 2018 (Incorporated
by reference to Exhibit 3.1 of the Current Report on Form 8-K filed on May 14, 2018).
3.4
Certificate
of Designations for Series B Preferred Stock. (Incorporated by reference to Exhibit 3.1 of the Current Report on Form 8-K filed on
April 2, 2019).
3.5
Amended
and Restated Bylaws of Ozop Surgical Corp. adopted on May 22, 2019. (Incorporated by reference to Exhibit 3.2 of the Current Report
on Form 8-K filed on May 22, 2019).
3.6
Amended
and Restated Articles of Incorporation as filed with the Nevada Secretary of State on July 25, 2019. (Incorporated by reference to
Exhibit 3.1 of the Current Report on Form 8-K filed on July 30, 2019).
3.7
Certificate
of Designation of Series C Preferred Stock. (Incorporated by reference to Exhibit 3.1 of the Current Report on Form 8-K filed on
September 24, 2019).
3.8
Certificate
of Withdrawal of Series B Preferred Stock. (Incorporated by reference to Exhibit 3.2 of the Current Report on Form 8-K filed on September
24, 2019).
3.9
Amended
and Restated Articles of Incorporation as filed with the Nevada Secretary of State on October 29, 2019. (Incorporated by reference
to Exhibit 3.2 of the Current Report on Form 8-K filed on October 31, 2019).
3.10
Amended
and Restated Articles of Incorporation as filed with the Nevada Secretary of State on December 30, 2020, (Incorporated by reference
to Exhibit 3.1 of the Current Report on Form 8-K filed on December 31, 2019) .
3.11
Amended
and Restated Articles of Incorporation as filed with the Nevada Secretary of State on January 21, 2020. (Incorporated by reference
to Exhibit 3.1 of the Current Report on Form 8-K filed on February 7, 2020).
3.12
Amended and Restated Certificate of Designation of Series C Preferred Stock. (Incorporated by reference to Exhibit 3.1 of the Current Report on Form 8-K filed on February 5, 2020).
11
3.13
Amendment
to Certificate of Designation of Series C Preferred Stock dated July 7, 2020 (Incorporated by reference to Exhibit 3.1 of the Current
Report on Form 8-K filed on July 10, 2020).
3.14
Certificate
of Designation of Series D Preferred Stock dated July 7, 2020 (Incorporated by reference to Exhibit 3.2 of the Current Report on
Form 8-K filed on July 10, 2020).
3.15
Certificate
of Designation of Series E Preferred Stock dated July 7, 2020 (Incorporated by reference to Exhibit 3.3 of the Current Report on
Form 8-K filed on July 10, 2020).
3.16
Articles
of Incorporation of Ozop Surgical Name Change Subsidiary, Inc. (Incorporated by reference to Exhibit 3.1 of the Current Report on
Form 8-K filed on November 13, 2020).
3.17
Articles
of Merger between Ozop Surgical Corp. and Ozop Surgical Name Change Subsidiary, Inc. (Incorporated by reference to Exhibit 3.2 of
the Current Report on Form 8-K filed on November 13, 2020).
3.18
Amended
and Restated Certificate of Designation Series D Preferred Stock dated July 27, 2021 (Incorporated by reference to Exhibit 3.1 of
the Current Report on Form 8-K filed on August 2, 2021).
3.19
Advisory
agreement between Ozop Capital and RMA dated September 1, 2021 (Incorporated by reference to Exhibit 10.1 of the Current Report on
Form 8-K filed on September 2, 2021)
10.1
Binding
Letter of Intent dated February 28, 2020, by and between Ozop Surgical Corp. and Power Conversion Technologies, Inc, and Catherine
Chis, (Incorporated by reference to Exhibit 10.1 of the Current Report on Form 8-K filed on February 28, 2020).
10.2+
Employment
Agreement dated February 28, 2020, by and between Ozop Surgical Corp. and Brian Conway, (Incorporated by reference to Exhibit 10.3
of the Current Report on Form 8-K filed on February 28, 2020).
31.1*
Certification
of Chief Executive Officer required by Rule 13a-14(1) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant
to Section 302 of the Sarbanes-Oxley Act of 2002
31.2*
Certification
of Chief Financial Officer required by Rule 13a-14(1) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant
to Section 302 of the Sarbanes-Oxley Act of 2002
32.1*
Certification
of Chief Executive Officer and the Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and Section
1350 of 18 U.S.C. 63
101.INS*
Inline
XBRL Instance Document
101.SCH*
Inline
XBRL Taxonomy Extension Schema Document
101.CAL*
Inline
XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF*
Inline
XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*
Inline
XBRL Taxonomy Extension Label Linkbase Document
101.PRE*
Inline
XBRL Taxonomy Extension Presentation Linkbase Document
104
Cover
Page Interactive Data File (embedded within the Inline XBRL document)
*
Filed herewith.
+
Management contract or compensatory plan or arrangement.
12
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned thereunto duly authorized.
Dated:
May 15, 2023
/s/
Brian P Conway
Brian
P. Conway
Chief
Executive Officer
(principal
executive officer)
(principal
financial and accounting officer)
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.